Since the beginning of August, Switzerland has joined the European countries that already allow the use of cannabis for medicinal purposes through prescription...
The legality of cannabis has dropped synthetic cannabinoid poisonings, according to a study led by Tracy Klein of Washington State University. Through the...
Autism is a developmental neurological condition present from childhood and permanent, which is usually characterized by difficulties in communication and interaction...
A survey carried out by the American company “The Harris Poll”, on behalf of Curaleaf Holdings, reveals that 91% of adults aged 21 and over who have used...
A new educational platform was launched this week by Tilray Medical, with the aim of informing healthcare professionals, caregivers and patients about the use...
Bonni Goldstein, the Los Angeles pediatrician who specializes in cannabinoid treatments, said last Wednesday in London that "it may sound brutal, but a dead child...
The evaluation of applications for submission of cannabidiol (CBD) as a novel food at the European Food Safety Agency (EFSA) is suspended, after a note published by...
According to the European Union (EU), cancer is the second leading cause of mortality in EU countries, after cardiovascular diseases. All the...
An American study published in the journal Wiley - Health Economics reveals that patients in the "Medicaid" health program reduced their use of prescription drugs after...
Curaleaf International has licensed a line of cannabis extract-based medicines in Malta. The product range is being manufactured to...